Publications2019-03-29T16:10:50+00:00

Innovations

List of Publications

Cumulative “Impact Factor” is currently at 98,35.

Original Publications as First- or Senior Author Prof Dr Dr D. Dian

  1. W Janni, M Kiechle, H Sommer, B Rack, K Gauger, M Heinrigs, D Steinfeld, D Augustin, W Simon, N Harbeck, K Friese, D Dian: Participation in study improves treatment strategies and individual patient care in the participating centres. Geburtsh Frauenheilk 2005 Okt; 65(10) 966-73 (IF 0,76)
  2. D Dian, G Hemminger; W Janni; K Friese; F Jänicke: Management of skin-sparing mastectomy: Results of a Survey of German Hospitals. Onkologie 2006;29:267-70 (IF 1,72)
  3. D Dian, K Schwenn, K Friese, F Jänicke: Morbidity after mastectomy and immediate autologous reconstruction. Geburtsh Frauenheilk 2006 May; 66:469-73 (IF 0,69)
  4. D Dian, K Schwenn, I Mylonas, W Janni, K Friese, F Jaenicke: Quality of life among breast cancer patients undergoing autologous breast reconstruction versus breast conservative therapy. J Cancer Res Clin 2007 Apr;133(4):247-52 (IF2,37)
  5. D Dian, K Schwenn , I Mylonas, W Janni, F Jaenicke, K Friese: Aesthetic result among breast cancer patients undergoing autologous breast reconstruction versus breast conserving therapy. Archives of Gynecology and Obstetrics 275(6) 445-50 2007 Jun (IF 0,67)
  6. D Dian, R Muggendorfer, W Janni, K Friese: Breast conserving therapy versus mastectomy: Long term results from a matched pair analysis. Geburtsh Frauenheilk 2007 Dez; 67: 1328-33 (IF 0,35)
  7. D Dian, J Straub , C Scholz, I Mylonas, B Rack, H Sommer, W Janni, K Friese: Influencing factors for regional recurrence of breast cancer. Archives of Gynecology and Obstetrics 2008 Feb; 277: 127-134 (IF 0,73)
  8. D Dian, B Rack, V Drinovac, I Mylonas, W Janni, K Friese: First experiences worldwide with NOTES in gynaecology. Geburtsh Frauenheilk 2008 Sep; 68(9): 930-3 (IF 0,35)
  9. D Dian, W Janni, Ch Kuhn, D Mayr, U Karsten, I Mylonas, K Friese, U Jeschke: Evaluation of a novel anti-mucin 1 (MUC1) antibody (Panko-Mab) as a potential diagnostic tool and comparison with two established antibodies against this antigen in human ductal breast cancer. Onkologie 2009 32(5) 238-44 (IF 1,23)
  10. D Dian, H Sommer, R Wilkowski, K Friese: First experiences with vacuum-assisted closure as alternative treatment method to repair defects of an extended thoracic wall recurrence of breast cancer. Geburtsh Frauenheilk 2009 Jan 69(1) 50-54 (IF 0,35)
  11. D Dian, H Herold, I Mylonas, C Scholz, W Janni, H Sommer, K Friese: Survival analysis between patients with invasive ductal and invasive lobular breast cancer. Archives of Gynecology and Obstetrics 2009 Jan; 279(1) 23-8 (IF 0,91)
  12. D Dian, V Drinovac, I Mylonas, K Friese: Worldwide First Successful Splitting of the Breast for a Single-Procedure Reconstruction after Mastectomy with Maintaining the Sensitivity. Archives of Gynecology and Obstetrics 2009 Okt; 280/4) 539-42 (IF 0.91)
  13. D Dian, V Bodungen, I Himsl, V Drinovac, I Mylonas, H Sommer, K Friese: Worldwide first experiences with vacuum-assisted closure as alternative treatment method to repair defects of an extended thoracic wall recurrence of breast cancer. Archives of Gynecology and Obstetrics 2010 May 281(5) 927-32 (IF 1,07)
  14. TM Weissenbacher, M Zschage, W Janni, U Jeschke, T Dimpfl, D Mayr, B Rack, C Schindlbeck, K Friese, D Dian: Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat 2010 Jul;122(1)27-34 (IF 4,86)
  15. T Weissenbacher, C Kuhn, D Mayr, R Pavlik, K Friese, C Scholz, U Jeschke, N Ditsch, D Dian: Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium Anticancer Research. 2011 Feb;31(2):451-7 (IF 1.73)
  16. D Dian, A Bruening, I Mylonas: E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis. Archives of Gynecology and Obstetrics. 2011 Aug 284(2): 437-43 (IF 1,28)
  17. I Mylonas, D Dian: Inhibin-α subunit in normal and malignant human cervical tissue and cervical cancer cell lines: Oncology Reports 2011 Okt 26(4): 887-91 (IF 1,84)
  18. D Dian, T Vrekoussis, N Shabani, I Mylonas, C Kuhn, C Schindlbeck ,I Navrozoglou, K Friese, A Makrigiannakis. U Jeschke: Expression of Cathepsin-D in Primary Breast Cancer and Corresponding Local Recurrence or Metastasis: An Immunohistochemical Study; Anticancer Research. 2012 Mar 32(3):901-5 (IF 1.73)
  19. M v Wolff; D Dian: Fertility Preservation in Women With Malignant Tumors and Gonadotoxic Treatments; Dtsch Arztebl Int 2012 Mar 109(12): 220-6 (IF 2,92)
  20. I Wiest, C Alexiou, C Kuhn, S Schulze, S Kunze, D Mayr, P Betz, U Jeschke, D Dian: Expression of Different Carbohydrate Tumour Markers and Galectins 1 and 3 in Normal Squamous and Malignant Epithelia of the Upper Aaerodigestive Tract; Anticancer Research. 2012 May 32(5):2023-9 (IF 1.73)
  21. U Jeschke, I Wiest, A Schumacher, M Kupka, B Rack, R Stahn, U Karsten, D Mayr, K Friese, D Dian: Determination of MUC1 in Sera of Ovarian Cancer Patients and in Sera of Patients with Benign Changes of the Ovaries with CA15-3, CA27.29, and PankoMab; Anticancer Research. 2012 May 32(5):2185-9 (IF 1.73)
  22. I Himsl, V Drinovac, M Lenhard, D Stoeckl, T Weissenbacher, D Dian: The use of porcine acellular dermal matrix in silicone implant-based breast reconstruction; Archives of Gynecology and Obstetrics. 2012 Mar 286(1)187-92 (IF 1,28)
  23. D Dian, M Lenhard, D Mayr, U Karsten, C Kuhn, K Friese, T Weissenbacher, U Jeschke: Staining of MUC1 in ovarian cancer tissues with PankoMab-GEXTM detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8; Histology and histopathology. 2013 Feb;28(2):239-4.(IF 2,48)
  24. T Vrekoussis, M Perabo, I Himsl, M Günthner-Biller, D Dian: Bilateral prophylactic skin-reducing nipple sparing mastectomy with immediate breast reconstruction using only a vascularized dermal-subcutaneous pedicle: Technique and possible advantages. Archives of Gynecology and Obstetrics. 2012 (IF 1,28)
  25. S. Heublein, T Vrekoussis, D Mayr, K Friese, M Lenhard, U Jeschke, D Dian: Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR); Journal of Ovarian Research. 2013 – accepted – editor letter attached.(IF 2,57)
  26. T Weissenbacher, T Vrekoussis, D Roeder, A Makrigiannakis, D Mayr , N Ditsch, K Friese , U Jeschke, D Dian: Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression. International Journal of Molecular Sciences 2013, 14, 4783-4792 (IF 2.60)
  27. D Richter, S Abarzua, M Chrobak, T Vrekoussis, T Weissenbacher, C Kuhn, S Schluze, M Kupka, K Friese, V Briese, B Piechulla, A Makrigiannakis, U Jeschke, D Dian: Effects of Phytoestrogen Extracts Isolated from Pumpkin seeds on Estradiol Production and ER/PR Expression in Breast Cancer and Trophoblast Tumour Cells. Nutr Cancer. 2013 Jul;65(5):739-45 (IF 2,78)
  28. D Dian, I Wiest, L Barthell, K Friese, U Jeschke: Significance of the Tumor Protease Cathepsin D for the Biology of Breast Cancer. Histology and histopathology. 2013 (IF 2,48)
  29. J Jückstock, T Kimmich, A Brüning, I Mylonas, D Dian: The inhibin-betaC subunit is downregulated, while inhibin-betaE is up regulated by interferon-beta1a in Ishikawa carcinoma cell line. Archives of Gynecology and Obstetrics. 2013 Apr 12 (IF 1,28)
  30. M L Buchholtz, J Jückstock, E Weber, I Mylonas, A Brüning, D Dian: Loss of LDOC1 Expression by Promoter Methylation in Cervical Cancer Cells. Cancer Investigation 2013 Okt 14 (IF 2,24)
  31. M M Karsten, S Enders, J Knabl, V Kirn, P Düwell, B Rack, J U Blohmer, D Mayr, D Dian: Biologic meshes and synthetic meshes in cancer patients: a double-edged sword: differences in production of IL-6 and IL-12 caused by acellular dermal matrices in human immune cells. Archives of Gynecology and Obstetrics 2018 Feb 7 (IF 2,09)

Originalarbeiten Koautor Prof. Dr. Dr. D. Dian

  1. W Janni, B Rack, B Gerber, I Bauernfeind, A Krause, D Dian, H Sommer, K Friese: Pregnancy-associated breast cancer – Special features in diagnosis and treatment. Onkologie 2006;29(3) 107-12 (IF 1,72)
  2. I Mylonas, U Jeschke, Ch Kunert-Keil, N Shabani, D Dian, I Bauerfeind, C Kuhn, M Kupka, K Friese: Glycodelin A is differentially expressed in normal human endometrial tissue throughout the menstrual cycle as assessed by immunohistochemistry and in situ hybridization. Fertil Steril 2006 Nov; 86(5)1488-97 (IF 3,28)
  3. I Mylonas, U Jeschke, N Shabani, Ch Kuhn, S Kunze, D Dian, Ch Friedl, M Kupka, K Friese: Steroid receptors ER alpha, ER beta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol 2007;22(2)169-76 (IF 2,01)
  4. C Schindlbeck, K Klauser, D Dian, W Janni, K Friese: Total laparoscopic hysterectomy in comparison with vaginal and abdominal proceeding. Geburtsh Frauenheilk 2007 May 67(5) 529-30 (IF 0,50)
  5. M Heinrigs, J Straub, D Dian, H Sommer, W Janni, K Friese: Risk analysis for the development of axillary relapse in primary operable breast cancer against the nodal status; Geburtsh Frauenheilk 2007 May 67(5): 518-9 (IF 0,50)
  6. A Hoeing, Ch Kuhn, N Shabani, S Schulze, A Gingelmaier, D Dian, U Jeschke, K Friese, I Mylonas: The immunohistochemical expression of the Inhibin/activin subunits are up regulated by interferon-b1a in Ishikawa cell line. Anticancer Research 2007 Jul; 27(4A)2005-10 (IF 1,41)
  7. I Mylonas, D Mayr, H Walzel, N Shabani, D Dian, Ch Kuhn, S Kunze, U Jeschke, K Friese: Mucin-1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinomas: an immunohistochemical analysis. Anticancer Research 2007 Jul; 27(4A)1975-80 (IF 1,41)
  8. N Shabani, Ch Kuhn, S Kunze, S Schulze, D Dian, A Gingelmaier, Ch Schindlbeck, F Willgeroth, H Sommer, U Jeschke, K Friese, I Mylonas: Prognostic significance of oestrogen receptor alpha (ER alpha) and beta (ER beta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. European Journal of Cancer 2007 Nov; 43(16) 2434-44 (IF 4,45)
  9. C Schindlbeck, K Klauser, D Dian, U Jeschke, W Janni, K Friese: Comparison of total laparoscopic, vaginal and abdominal hysterectomy. Archives of Gynecology and Obstetrics 2008; 277(4)331-337 (IF 0,73 )
  10. N Bassarak, T Blankenstein, N Shabani, D Dian, K Friese: I Mylonas: Is Lymphadenectomy a prognostic marker in endometrioid adenocarcinomas of the human endometrium? Anticancer Research 2008 Nov, 28(68) 403171 (IF 1,39)
  11. I Mylonas, J Makovitzky, N Shabani, A Gingelmaier, D Dian, C Kuhn, S Schulze, S Kunze, U Jeschke, K Friese: Development and characterisation of an antibody for the immunohistochemical detection of inhibin/activin betaE (betaE) in normal human ovarian and placental tissue. Acta Histochem. 2009;111(4):366-71 (IF 1,23)
  12. I Mylonas, S Worbs, N Shabani, C; Kuhn, S; Kunze, S; Schulze, D Dian, A Gingelmaier, C Schindlbeck, A Bruening, H Sommer, U Jeschke, K Friese: Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: Analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases. European Journal of Cancer 2009 May 45(7) 1304-14 (IF 4,12)
  13. F Bergauer, A Brüning, N Shabani, T Blankenstein, J Jückstock, D Dian, I Mylonas: Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines. J Mol Histol. 2009 Dec 24 (IF 1,51)
  14. I Mylonas, T Blankenstein, N Bassarak, A Bruening, D Dian, F Bergauer, K Friese: Lymphadenectomy as a prognostic marker in endometrioid adenocarcinomas of the human endometrium. Onkologie 2010 Feb 33 108 (IF 1,16)
  15. N Bassarak, T Blankenstein, A Brüning, D Dian, K Friese, I Mylonas: Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium BMC Cancer. 2010 May; 10 224 (IF 2,74)
  16. S Ennemoser, M Schönfeld, V von Bodungen, D Dian, K Friese, K Jundt: Clinical relevance of occult stress urinary incontinence (OSUI) following vaginal prolapse surgery: long-term follow-up. Int Urogynecol J. 2012 Jul (IF 1,83)
  17. S Guenther, Th Vrekoussis, S Heublein, B Bayer, D Anz, J Knabl, I Navrozoglou, D Dian, K Friese, A Makrigiannakis, U Jeschke: Decidual Macrophages Are Significantly Increased in Spontaneous Miscarriages and Over-Express FasL: A Potential Role for Macrophages in Trophoblast Apoptosis. International Journal of Molecular Sciences; 2012 Jul 13(7) 9069-80 (IF 2,60)
  18. T Weissenbacher, RP Laubender, S Witkin, A Gingelmaier, B Schiessl, F Kainer, K Friese, U Jeschke, D Dian, K Karl: Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth. Arch Gynecol Obstet. 2012 Nov (IF 1,28)
  19. T Weissenbacher, E Hirte, C Kuhn, W Janni, D Mayr, U Karsten, B Rack, K Friese, U Jeschke,S Heublein, D Dian, N Ditsch: Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology. BMC Cancer. 2013 Jul 26;13:361(IF 3,33)
  20. A Kölbl, U Jeschke, D Dian, K Friese, U. Andergassen: Glycodelin A – A Famous Lipocalin and its Role in Breast Cancer. Anticancer Research. 2014 (IF 1.73)
  21. I Wiest, C Alexiou, K Friese, P Betz, J Tübel, S Goletz, D Dian, U Jeschke: Expression of the Tumor-associated Mucin 1 Epitope Analyzed with the Humanized PankoMab-GEX Antibody in Malignant and Normal Tissues of the Head and Neck. Anticancer Res. 2016 Jun;36(6):3179-84(IF 1.73)
  22. M Pazos, S Corradini, D Dian, V von Bodungen, N Ditsch, R Wuerstlein, S Schönecker, N Harbeck, H Scheithauer, C Belka: Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction: An alternative treatment option for locally advanced breast cancer. Strahlenther Onkol. 2017 Apr;193(4):324-331 (IF 2,898)

Übersichtsarbeiten Erst-/Seniorautor Prof. Dr. Dr. D. Dian

  1. D Dian = Djavadian: Möglichkeiten der modernen plastischen Brustchirurgie I. Hamburger Ärzteblatt 11/03: 481
  2. D Dian: Möglichkeiten der modernen plastischen Brustchirurgie II. Frauenarzt 46(2005) Nr. 9: 766
  3. D Dian: Möglichkeiten der modernen plastischen Brustchirurgie III. Journal der DGPW (Deutschen Gesellschaft für Plastische und Wiederherstellungschirurgie) Nr. 34/2006:19-23
  4. D Dian, K Schwenn, K Friese, F Jänicke: Morbidity after Mastectomy and Immediate Autologous Reconstruction. Senologie 2006; 3: 233-237
  5. D Dian, B Rack, Ch Schindlbeck, W Janni, K Friese: Die endoskopische Hysterektomie: LAVH, LASH, TLH und NOTE-AVH. Der Gynäkologe 2007
  6. D Dian, K Friese: Onkoplastische Operationen beim Mammakarzinom. Der Gynäkologe 2008
  7. D Dian, K Friese: Augmentation und Korrekturoperationen der Brust. Der Gynäkologe 2008
  8. D Dian: NOTES – Verfahren mit Zukunft oder kurzes Intermezzo? Ambulante Chirurgie Vol. 13 Ausgabe 2 April 2009
  9. D Dian, C Scholz, T Weissenbacher, K Friese: Narbenfreies Operieren (NOTES) in der Gynäkologie. Der Gynäkologe 2010
  10. D Dian, C Scholz, T Weissenbacher, K Fries: Staging und Therapie des Zervixkarzinoms – der minimal invasive Zugang. Der Gynäkologe 2010
  11. T Weissebacher, C Scholz, K Friese, D Dian: NOTES – narbenfreies Operieren in der Gynäkologie. Gynäkologie und Geburtshilfe 2010
  12. M Perabo, V von Bodungen, V Drinovac, I Hiemsl, D Dian: Breast reconstruction with Porcine dermal matrix; Geburtsh Frauenheilk 2011 Jun 71(6) 545-7

Übersichtsarbeiten Koautor Prof. Dr. Dr. D. Dian

  1. G Bickel-Weirauch, C Zahner, D Dian = Djavadian, C Neuhofer, J Gauwerky: Konservative Therapie der Streßharninkontinenz. GynSpektrum 10/99
  2. G Bickel-Weirauch, D Dian = Djavadian, J Gauwerky: Zervikale leukozytäre Infiltration als Erstsymptom einer akuten myeloischen Leukämie. GynSpectrum 3/99
  3. J Gauwerky, D Dian = Djavadian: Reduktionsplastik mit zentraler Stielung des Mamillen-Areola-Komplexes und Mastopexie durch Epidermislappen: Gynäkologische Praxis 1/2001
  4. I Mylonas, D Dian, K Friese: Antibiotikatherapie in der Schwangerschaft. Der Gynäkologe. 38: 761 – 770.
  5. W Janni, H Sommer, D Dian, K Friese: Zervixkarzinom – Die Nachsorge: Onkologie heute 06/2005: 37
  6. W Janni, B Gerber, H Sommer, M Untch, A Krause, D Dian, I Runnebaum, B Rack, K Friese: Therapie des primären, invasiven Mammakarzinoms. Deutsches Ärzteblatt 102, Ausgabe 41 vom 14.10.2005, Seite A-2795 / B-2360 / C-2226

Buchbeiträge Prof. Dr. Dr. D. Dian

  1. J Gauwerky, D Dian = Djavadian: Medikamentöse Behandlung des Uterus myomatosus, Kapitel im Buch „Uterus myomatosus“. Springer Verlag
  2. D Dian et al: Kapitel Behandlung des lokalen und regionären Tumorrezidivs, Manual Mammakarzinom, Tumorzentrum München und W. Zuckerschwerdt Verlag 2009
  3. D Dian et al: Kapitel Operative Therapie des primären Mammakarzinoms und Rekonstruktionsverfahren, Manual Mammakarzinom, Tumorzentrum München und W. Zuckerschwerdt Verlag 2009
  4. D Dian et al: Kapitel Behandlung des lokalen und regionären Tumorrezidivs, Manual Mammakarzinom, Tumorzentrum München und W. Zuckerschwerdt Verlag 2009
  5. D Dian et al: Kapitel Sonderfälle, Manual Mammakarzinom, Tumorzentrum München und W. Zuckerschwerdt Verlag 2009
  6. U Jeschke, I Wiest, Ch Schndlbeck, D Dian, K Friese: Galactins, Glycans, and Mucins as Targets for Novel and Specific Antibody Therapies in Gynecologic Cancer Therapies 2011
  7. D Dian et al: Kapitel Behandlung des lokalen und regionären Tumorrezidivs, Manual Mammakarzinom, Tumorzentrum München und W. Zuckerschwerdt Verlag 2009
  8. D Dian et al: Kapitel Operative Therapie des primären Mammakarzinoms und Rekonstruktionsverfahren, Manual Mammakarzinom, Tumorzentrum München und W. Zuckerschwerdt Verlag 2017
  9. D Dian et al: Kapitel Lokoregionäre Therapieoptionen im metastasierten Stadium, Manual Mammakarzinom, Tumorzentrum München und W. Zuckerschwerdt Verlag 2017

Fallberichte Erstautor Prof. Dr. Dr. D. Dian

  1. D Dian = Djavadian, I Witzel, J Gauwerky, F Jänicke: Laparoscopic oophoropexy for the treatment of recurrent torsion of the adnexa in pregnancy: case report and review of the literature. Fertility and Sterility 10/2004 (IF 3,17)
  2. D Dian = Djavadian; W Braendle; F Jänicke: Ovarian Pregnancy as a Differential Diagnosis in Unclear Ovarian Tumours: Case Report and Review of the Literature. Geburtsh Frauenheilk 2004; 64: 304-307 (IF 0,63)
  3. D Dian, H Sommer, R Wilkowski, I Mylonas, W Janni, K Friese: First Experiences with Vacuum Assisted Closure (V.A.C.) as Alternative Treatment Method to Repair Defects of an Extended Thoracic Wall Recurrence of the Mastocarcinoma. Geburtsh Frauenheilk 2009 (IF 0,35)

Abstract Erst-/Seniorautor Prof. Dr. Dr. D. Dian

  1. B Rack, V Drinovac, C Schindibeck, W Janni, K Friese, D Dian: First experiences worldwide with NOTES in gynaecology. Geburtsh Frauenheilk 2008 May; 68(5): 541 (IF 0,35)
  2. Jeschke U, Wiest I, Schumacher A, Kupka M, Stahn R, Karsten U, Friese K, Dian D: Determination of MUC1 in Sera of Ovarian Cancer Patients and in Sera of Patients with Benign Changes of the Ovaries with CA15-3, CA27.29, and PankoMab. Anticancer Research. 2011 May 31(5) 1983-4 (IF 1,73)
  3. I Wiest, C Kuhn, S Hofmann, S Schulze, D Mayr, S Heublein, T Weissenbacher, C Friedl, K Friese, U Jeschke, D Dian: PankoMab-GEX TM, also as diagnostic Antibody in Breast Cancer; Geburtsh Frauenheilk 2012 Jul 72(7) (IF 0,82)

Abstract Koautor Prof. Dr. Dr. D. Dian

  1. A Tsvilina, D Dian, F Kainer, K Friese . Are the intra abdominal adhesion from uterus for front abdomen wall in Z.n. Caesarean operation according to Misgav-Ladach-Method considered as risks for further pregnancy and potential hindrance in the childbirth. Geburtsh Frauenheilk 2008 May;68:550 (IF 0,35)
  2. I Mylonas, S Worbs, N Shabani, D Dian, U Jeschke, K Friese: Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas, Geburtsh Frauenheilk 2008 Sep; 68: 10 (IF 0,35)